Rompoti, Natalia <br/><br/>
Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study.  [electronic resource] 

 -  Dermatologic therapy  09 2019 
 - e13006 p.  digital 
<br/><br/> Publication Type: Clinical Study; Journal Article 
<br/><br/><label>ISSN: </label>1529-8019 
<br/><br/><label>Standard No.: </label>10.1111/dth.13006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Ankle<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Interleukin-17--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Psoriasis--diagnosis<br/>Scalp<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult